Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of <i>de novo</i> or acquired resistance and importance of combining the allosteric Akt inhibitor MK‐2206 with an aromatase inhibitorPaul Vilquin, Pascale A. Cohen, Marie Villedieu et al.|International Journal of Cancer|2013Cited by 47
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, Olivier Trédan et al.|ESMO Open|2021Cited by 35
Nouvelles stratégies thérapeutiques dans le cancer du sein hormono-dépendant métastatiquePaul Vilquin, Pierre-Étienne Heudel, Pascale A. Cohen et al.|Bulletin du Cancer|2015Cited by 7